Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet- induced obese mice

Diabetes

Volumn 64, Issue 3, 2015, Pages 867-875

  Kodama, Keiichi ^a,b   Toda, Kyoko ^c   Morinaga, Shojiroh ^c   Yamada, Satoru ^c   Butte, Atul J ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; CD44 MONOCLONAL ANTIBODY; GAMMA INTERFERON; GLUCOSE; HERMES ANTIGEN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; METFORMIN; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; PIOGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; COMPARATIVE STUDY; CONTROLLED STUDY; DIET INDUCED OBESITY; DIET RESTRICTION; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID STORAGE; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; REAL TIME POLYMERASE CHAIN REACTION; SOFT TISSUE INFLAMMATION; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; LIPID DIET; METABOLISM; OBESITY; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; DIET, HIGH-FAT; FATTY LIVER; INFLAMMATION; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; OBESITY;

EID: 84962092195     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0149     Document Type: Article

References (25)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444: 860-867
2. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011;121:2111-2117
3. Galgani JE, Moro C, Ravussin E. Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab 2008;295:E1009-E1017
4. Kodama K, Horikoshi M, Toda K, et al. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci U S A 2012;109:7049-7054
5. Toda K, Yamada S, Yamada Y, Irie J, Kodama K, Suzuki Y. Glucose metabolism in CD44-deficient mice. J Japan Diabetes Society 2012;55:S213 [in Japanese]
6. Kang HS, Liao G, DeGraff LM, et al. CD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistance. PLoS One 2013;8:e58417
7. Egan CE, Daugherity EK, Rogers AB, Abi Abdallah DS, Denkers EY, Maurer KJ. CCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model. PLoS One 2013;8:e65247
8. Liu L, Kodama K, Butte A, McLaughlin T, Wei K. The receptor CD44 is associated with insulin resistance in Caucasian subjects. Late-breaking abstract presented at ENDO 2013, 15-18 June 2013, Moscone Center, San Francisco, CA
9. Johnson P, Ruffell B. CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets 2009;8:208-220
10. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-1313
11. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996;271:509-512
12. Ashkar S, Weber GF, Panoutsakopoulou V, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000;287:860-864
13. Shi X, Leng L, Wang T, et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 2006; 25:595-606
14. Fogelstrand P, Borén J. Treatment of hyaluronan accumulation ameliorates high-fat diet-induced insulin resistance in mice. Diabetes 2013;62:1816-1817
15. Kang L, Lantier L, Kennedy A, et al. Hyaluronan accumulates with high-fat feeding and contributes to insulin resistance. Diabetes 2013;62:1888-1896
16. Nomiyama T, Perez-Tilve D, Ogawa D, et al. Osteopontin mediates obesityinduced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 2007;117:2877-2888
17. Chapman J, Miles PD, Ofrecio JM, et al. Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice. PLoS One 2010;5:e13959
18. Kiefer FW, Neschen S, Pfau B, et al. Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia 2011;54:2132-2142
19. Lancha A, Rodríguez A, Catalán V, et al. Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice. PLoS One 2014;9:e98398
20. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294:E15-E26
21. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509
22. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988;37:1163-1167
23. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112:1821-1830
24. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116:1494-1505
25. Brocke S, Piercy C, Steinman L, Weissman IL, Veromaa T. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci U S A 1999;96:6896-6901